Comparative effectiveness of aspirin dosing in cardiovascular disease

W. Schuyler Jones, Hillary Mulder, Lisa M. Wruck, Michael J. Pencina, Sunil Kripalani, Daniel Muñoz, David L. Crenshaw, Mark B. Effron, Richard N. Re, Kamal Gupta, R. David Anderson, Carl J. Pepine, Eileen M. Handberg, Brittney R. Manning, Sandeep K. Jain, Saket Girotra, Danielle Riley, Darren A. DeWalt, Jeff Whittle, Ythan H. GoldbergVeronique L. Roger, Rachel Hess, Catherine P. Benziger, Peter Farrehi, Li Zhou, Daniel E. Ford, Kevin Haynes, Jeffrey J. VanWormer, Kirk U. Knowlton, Jennifer L. Kraschnewski, Tamar S. Polonsky, Dan J. Fintel, Faraz S. Ahmad, James C. McClay, James R. Campbell, Douglas S. Bell, Gregg C. Fonarow, Steven M. Bradley, Anuradha Paranjape, Matthew T. Roe, Holly R. Robertson, Lesley H. Curtis, Amber G. Sharlow, Lisa G. Berdan, Bradley G. Hammill, Debra F. Harris, Laura G. Qualls, Guillaume Marquis-Gravel, Madelaine F. Modrow, Gregory M. Marcus, Thomas W. Carton, Elizabeth Nauman, Lemuel R. Waitman, Abel N. Kho, Elizabeth A. Shenkman, Kathleen M. McTigue, Rainu Kaushal, Frederick A. Masoudi, Elliott M. Antman, Desiree R. Davidson, Kevin Edgley, James G. Merritt, Linda S. Brown, Doris N. Zemon, Thomas E. McCormick, Jacqueline D. Alikhaani, Kenneth C. Gregoire, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez, Oana A. Sandu

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Comparative effectiveness of aspirin dosing in cardiovascular disease'. Together they form a unique fingerprint.

Medicine & Life Sciences